Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Healthy Adolescents
Clinical trial NCT02199691 · COMPLETED
Trial details
- NCT number
- NCT02199691
- Sponsor
- Sanofi Pasteur, a Sanofi Company
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-07-22
- Primary completion
- 2015-10-02
- Enrollment
- 1715
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.